Key Takeaways
- • American Industrial Partners is acquiring Avanos Medical Inc. in an all-cash take-private transaction valued at approximately $1.3 billion, with the deal announced on April 14, 2026.
- • Avanos Medical stock surged 67% in premarket trading on the announcement date, reflecting significant shareholder value delivery through the acquisition price.
- • The transaction is being steered by three law firms, indicating a complex multi-party acquisition structure typical of substantial private equity take-private deals.
- • The all-cash structure eliminates financing risk and provides certainty of closing for shareholders, a material consideration for institutional investors evaluating the transaction.
Summary
American Industrial Partners has agreed to acquire Avanos Medical Inc. in an all-cash take-private transaction valued at nearly $1.3 billion, the company announced on April 14, 2026. The deal represents a significant exit event for public equity shareholders, with the stock price jumping 67% in premarket trading ahead of the market open on announcement day, reflecting market confirmation of the transaction terms.
The acquisition is being executed as a take-private transaction, meaning the combined entity will be delisted from public markets following closing. The all-cash structure provides immediate certainty to shareholders regarding deal completion, eliminating the contingency risk typically associated with stock-consideration or mixed-consideration structures. Three law firms have been retained to guide the transaction through completion, a standard practice for acquisitions of this scale involving complex corporate and regulatory considerations.
The transaction demonstrates sustained activity in the healthcare technology and medical device sector, where strategic acquirers and private equity firms continue to identify consolidation opportunities. American Industrial Partners' acquisition of Avanos represents a notable take-private event for institutional investors monitoring exit opportunities and portfolio company valuations within the medtech ecosystem.
The acquisition is being executed as a take-private transaction, meaning the combined entity will be delisted from public markets following closing. The all-cash structure provides immediate certainty to shareholders regarding deal completion, eliminating the contingency risk typically associated with stock-consideration or mixed-consideration structures. Three law firms have been retained to guide the transaction through completion, a standard practice for acquisitions of this scale involving complex corporate and regulatory considerations.
The transaction demonstrates sustained activity in the healthcare technology and medical device sector, where strategic acquirers and private equity firms continue to identify consolidation opportunities. American Industrial Partners' acquisition of Avanos represents a notable take-private event for institutional investors monitoring exit opportunities and portfolio company valuations within the medtech ecosystem.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.